相似文献
1
Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.
J Clin Microbiol. 2002 Oct;40(10):3551-7. doi: 10.1128/JCM.40.10.3551-3557.2002.
2
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.
J Clin Microbiol. 2002 Apr;40(4):1298-302. doi: 10.1128/JCM.40.4.1298-1302.2002.
3
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Antimicrob Agents Chemother. 2008 Apr;52(4):1506-9. doi: 10.1128/AAC.01595-07. Epub 2008 Feb 19.
4
Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain.
J Clin Microbiol. 2010 Nov;48(11):4200-6. doi: 10.1128/JCM.00920-10. Epub 2010 Sep 8.
5
Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil.
Clin Microbiol Infect. 2010 Jul;16(7):885-7. doi: 10.1111/j.1469-0691.2009.03020.x. Epub 2009 Aug 17.
6
Pharmacological advances in the treatment of invasive candidiasis.
Expert Rev Anti Infect Ther. 2006 Feb;4(1):137-49. doi: 10.1586/14787210.4.1.137.
7
[Antifungal susceptibility of Candida species causing candidemia in Kurume University Hospital and Shaiseikai Hutukaichi Hospital].
Kansenshogaku Zasshi. 2005 Jan;79(1):20-4. doi: 10.11150/kansenshogakuzasshi1970.79.20.
8
[Profile of antifungal susceptibility of species of Candida isolated from hemocultures in a university hospital, Maracaibo, Venezuela].
Rev Iberoam Micol. 2006 Jun;23(2):97-100. doi: 10.1016/s1130-1406(06)70022-5.
9
Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.
Diagn Microbiol Infect Dis. 1999 Apr;33(4):217-22. doi: 10.1016/s0732-8893(98)00160-6.
10
Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii.
J Clin Microbiol. 2002 Jun;40(6):2266-9. doi: 10.1128/JCM.40.6.2266-2269.2002.
引用本文的文献
1
Biocontrol of Pathogen Microorganisms in Ripened Foods of Animal Origin.
Microorganisms. 2023 Jun 14;11(6):1578. doi: 10.3390/microorganisms11061578.
2
Probiotics and their postbiotics for the control of opportunistic fungal pathogens: A review.
Biotechnol Rep (Amst). 2023 May 4;38:e00800. doi: 10.1016/j.btre.2023.e00800. eCollection 2023 Jun.
3
Prevalence and Antifungal Susceptibility of Clinically Relevant Species, Identification of and in Bangladesh.
Trop Med Infect Dis. 2022 Aug 26;7(9):211. doi: 10.3390/tropicalmed7090211.
4
Colony Morphotype Forecasts Biofilm Formation of Clinical Isolates.
J Fungi (Basel). 2021 Jan 7;7(1):33. doi: 10.3390/jof7010033.
5
Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Species From 1997-2016.
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S79-S94. doi: 10.1093/ofid/ofy358. eCollection 2019 Mar.
6
Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997-2016.
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S54-S62. doi: 10.1093/ofid/ofy344. eCollection 2019 Mar.
7
Candidemia in patients with prolonged fever in Kashan, Iran.
Curr Med Mycol. 2016 Sep;2(3):20-26. doi: 10.18869/acadpub.cmm.2.3.20.
8
Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study.
Infection. 2016 Dec;44(6):747-755. doi: 10.1007/s15010-016-0924-9. Epub 2016 Jul 11.
9
Antifungal Susceptibility Analysis of Clinical Isolates of Candida parapsilosis in Iran.
Iran J Public Health. 2016 Mar;45(3):322-8.
10
Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa.
J Antimicrob Chemother. 2016 Jul;71(7):1994-2004. doi: 10.1093/jac/dkw091. Epub 2016 Apr 28.
本文引用的文献
1
Epidemiology of candidemia.
Rev Iberoam Micol. 2000 Sep;17(3):73-81.
2
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.
Clin Infect Dis. 2002 Sep 1;35(5):627-30. doi: 10.1086/342300. Epub 2002 Aug 2.
3
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
Antimicrob Agents Chemother. 2002 Jun;46(6):1723-7. doi: 10.1128/AAC.46.6.1723-1727.2002.
4
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.
J Clin Microbiol. 2002 Apr;40(4):1298-302. doi: 10.1128/JCM.40.4.1298-1302.2002.
5
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.
J Clin Microbiol. 2002 Mar;40(3):852-6. doi: 10.1128/JCM.40.3.852-856.2002.
6
Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases.
Antimicrob Agents Chemother. 2002 Feb;46(2):451-7. doi: 10.1128/AAC.46.2.451-457.2002.
7
Determining the value of antimicrobial surveillance programs.
Diagn Microbiol Infect Dis. 2001 Dec;41(4):171-5. doi: 10.1016/s0732-8893(01)00318-2.
8
The current status of surveillance of resistance to antimicrobial agents: report on a meeting.
J Antimicrob Chemother. 2002 Jan;49(1):17-23. doi: 10.1093/jac/49.1.17.
9
Antibiotic resistance surveillance: action for international studies.
J Antimicrob Chemother. 2002 Jan;49(1):7-10. doi: 10.1093/jac/49.1.7.
10
Antimicrobial resistance surveillance: methods will depend on objectives.
J Antimicrob Chemother. 2002 Jan;49(1):3-5. doi: 10.1093/jac/49.1.3.
Zotero 插件